BEGIN:VCALENDAR
VERSION:2.0
X-WR-CALNAME;VALUE=TEXT:Professor Alex Shalek (Massachusetts Institute of Technology)
PRODID:-//Harvard events data//EN
BEGIN:VEVENT
UID:event_1627536_0
SUMMARY:Professor Alex Shalek (Massachusetts Institute of Technology)
DESCRIPTION:<p><em>E. Bright Wilson Prize Lecture</em></p><p>Title:<strong> </strong><span><strong>IDENTIFYING &amp; COUNTERACTING THE IMPACT OF ENVIRONMENT STRESSES ON TISSUE DYSFUNCTION</strong></span></p><p>Abstract:</p><p class="text-align-justify"><span>During chronic stress, cells must support both tissue function and their own survival. Hepatocytes perform metabolic, synthetic, and detoxification roles; with chronic nutrient imbalances, metabolic stress can precipitate metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD/NASH). Despite prior work on stress-induced drivers of hepatocyte death, the functional impact of chronic stress on surviving cells remains unclear. In my talk, I will discuss how we used cross-species longitudinal single-cell multi-omic profiling to show that ongoing stress drives developmental and cancer-associated programs in non-transformed hepatocytes while reducing mature functional identity – significantly before transformation and predicting worsened human survival. Further, I will outline how we developed and applied integrative computational methods and experimental validations to uncover master regulators perturbing hepatocyte functional balance, increasing proliferation under stress, and directly priming future tumorigenesis. I will also explain how we utilized human tissue microarray spatial transcriptomics and geographic regression to reveal spatially-structured multicellular communities and signaling interactions shaping stress responses.&nbsp;Finally, toward counteracting these core mechanisms driving tissue dysfunction and instability, I will present our development of a new information-rich, high-throughput phenotypic screening platform, with&nbsp;reduced required sample, labor and cost requirements, that can be leveraged to help discover strategies to improve tissue health and resilience.&nbsp;</span></p><p class="text-align-justify"><span>Biography:</span></p><p class="text-align-justify"><span>Alex K. Shalek, PhD, is the Director of the Institute for Medical Engineering &amp; Science (IMES), the J. W. Kieckhefer Professor in the Department of Chemistry, and an Extramural Member of The Koch Institute for Integrative Cancer Research at MIT.&nbsp; He is also an Institute Member of the Broad Institute, a Member of the Ragon Institute, an Assistant in Immunology at MGB, and an Instructor in Health Sciences &amp; Technology at HMS. Dr. Shalek received his bachelor's degree </span><em><span>summa cum laude</span></em><span> from Columbia University and his Ph.D. from Harvard University in chemical physics under the guidance of Hongkun Park, and performed postdoctoral training under Hongkun Park and Aviv Regev (Broad/MIT). His lab’s research is directed towards the development and application of&nbsp;new approaches to elucidate cellular and molecular features that inform tissue-level function and dysfunction across the spectrum of human health and disease. Dr. Shalek and his work have received numerous honors including a NIH New Innovator Award, a Beckman Young Investigator Award, a Searle Scholar Award, a Pew-Stewart Scholar Award, the Avant-Garde (DP1 Pioneer) Award from the National Institute for Drug Abuse (NIDA), and an Alfred P. Sloan Research Fellowship in Chemistry, as well as the 2019-2020 Harold E. Edgerton Faculty Achievement Award at MIT and the 2020 HMS Young Mentor Award.</span></p><p>&nbsp;</p>
LOCATION:Pfizer Lecture Hall
STATUS:CONFIRMED
DTSTART:20260219T211500Z
DTEND:20260219T224500Z
END:VEVENT
END:VCALENDAR